[kj] mark of the beast closer than expected

[countessghoulita at aol.com]

 Well, I thought I was covered by the flu vaccine at that time. I could not afford getting sick (and thank god, my mom didn't, because she would have needed hospitalization). 


-----Original Message-----
From: Karen Weil <karen.weil at sddt.com>
To: A list about all things Killing Joke (the band!) <gathering at misera.net>
Sent: Tue, Jul 14, 2009 10:37 am
Subject: Re: [kj] mark of the beast closer than expected














I had a flu shot last October; didn't stop me from 
catching a mild strain of flu in late March -- for several miserable days. 



(Sorry you were so sick that time, 
Countess.)


 


k.w.


SoCal



  
----- Original Message ----- 

  
From: 
  countessghoulita at aol.com 

  
To: gathering at misera.net 

  
Sent: Tuesday, July 14, 2009 10:30 
  AM

  
Subject: Re: [kj] mark of the beast 
  closer than expected

  



  



  
The last flu shot I had was in 
  2004. In January 2005 I had the worst flu ever, with pneumonia-like symptoms. 
  I had to be treated with serious penicillin shots and codein (yeah, right 
  someone could be in envy) for 2 weeks. I don't care, I will never ever get 
  vaccinated again. 


  


-----Original Message-----
From: folk devil <folk.devil at hotmail.com>
To: 
  gathering at misera.net
Sent: Tue, Jul 14, 2009 10:26 am
Subject: Re: [kj] 
  mark of the beast closer than expected


  

  

  
seems that link is 'limited'...


  
 

  
Influenza Antiviral Resistance: Issues for Consideration 
  December 19, 2008 Background 

  

    


    
• 
CDC recommends annual influenza vaccination as the first and most 
    important step in preventing the flu. 


  

    


    
• Antiviral medications with activity against influenza v iruses are a 
    second line of defense against influenza. 



  

    


    
• Antiviral medications are important to consider especially for 
    treatment of patients with severe influenza or patients at higher risk for 
    influenza-related complications. 



  

    


    
• There are four antiviral medications approved for use in the United 
    States: oseltamivir, zanamivir, amantadine and rimantadine. 
    



  

    

      


      
o 
Oseltamivir and zanamivir have activity 
      against influenza A and B viruses. 



  

    

      


      
o 
Aman tadine and rimantadine have activity 
      against influenza A viruses, but not against influenza B viruses. 
      



  

    


    
• Influenza viruses can develop resistance to antiviral medications. 
    



  

    


    
• Since 2006, CDC has recommended the use of oseltamivir and zanamivir 
    against seasonal influenza=2
0because of a high resistance to amantadine and 
    rimantadine among influenza A (H3N2) viruses. 



  

    


    
• In the last two years, CDC has enhanced surveillance efforts for the 
    detection of viruses resistant to oseltamivir (Tamiflu
®) and 
    zanamivir (Relenza®). 


  

    


    
• These enhanced efforts have provided CDC with the capability to detect 
    resistant=2 0strains more quickly, and enabled CDC to monitor for changing 
    trends over time. 



  

    


    
• During the 2007-08 influenza season, a small increase in the number of 
    influenza viruses resistant to oseltamivir was observed. 
    



  

    


    
• CDC’s influenza season summary for 2007-2008 reported that 10.9% of 
    tested influenza A (H1N1) viruses were resistant to oseltamivir. 
    



  

    


    
• Last season, CDC tested 1,769 viruses for antiviral resistance. 
    



  

    


    
• During the 2007-08 influenza season in the Northern Hemisphere, 
    oseltamivir resistance of H1N1 viruses varied in different countries: from 
    0% to 70% in some European countries. 



  

    


    
• During the 2008 Southern Hemisphere season, oseltamivir resistance of 
    H1N1 viruses continued to be reported, with so
me Southern Hemisphere 
    countries reporting that a majority of tested A (H1N1) viruses were 
    resistant to oseltamivir. 



  
Current Situation 

  

    


    
• 
At this point in the season, a low level of influenza activity has 
    been reported in the United States. As a result, very few viruses have been 
    available for testing thus far. 

1 
  of 3 December 19, 2008 Influenza Antiviral Resistance: 
  Discussion Points (continued from previous page) 
  

  

    


    
• Early and limited data from this season has detected a significant 
    increase in the proportion of influenza A (H1N1) viruses that are resistant 
    to oseltamivir. 


    


    
• In the latest CDC FluView report published on December 19, 2008, 78 
    influenza viruses from 15 states had been tested for antiviral resistance. 
    



  

    


    
• This includes 50 influenza A (H1N1) viruses, 8 influenza A (H3N2 
    viruses) and 20 influenza B viruses. 



  

    


    
• Preliminary data show: 



  

    

      


      
o 
49 of the 50 influenza A (H1N1) viruses tested 
      were resistant to oseltamivir (98%). 



  

    

      


      
o 
These oseltamivir resistant viruses have been 
      detec
ted in 12 states, but the majority of samples have come from two 
      states. 



  

    

      


      
o 
All 50 influenza A (H1N1) viruses were 
      sensitive to zanamivir and amantadine and rimantadine. 
      



  

    

      


      
o 
All 8 influenza A (H3N2) viruses remain 
      sensitive to oseltamivir and zanamivir. 



  

    

      


      
o 
All 20 influenza B viruses remain sensitive to 
      oseltamivir and zanamivir. 



  

    

      


      
o 
All influenza A(H3N2) viruses tested were 
      resistant to amantadine and rimantadine. 



  

    


    
• Weekly reports summarizing U.S. surveillance activity are published 
    every Friday from October through mid-May at 
http://www.cdc.gov/flu/weekly/fluactivity.htm 


  

    

    
• 
The fact that oseltamivir-resistance is 
    significantly higher among H1N1 viruses compared to last season in the U.S. 
    is not surprising. Worldwide, the proportion of H1N1 viruses that are 
    resistant to oseltamivir has been increasing. 
  



  

    


    
• Influenza viruses=2 0change constantly through changes in their 
    genetic makeup, and one of such mutations conferred resistance to 
    oseltamivir. 



 20

    


    
• There is no evidence that the resistant viruses are causing more 
    severe illness than other influenza viruses or that they are transmitted 
    differently. 



  

    


    
• At this time, it’s not possible to predict how common H1N1 viruses 
    will be during the rest of the 2008–09 season, as every influenza season is 
    different. 


    


    
• CDC is monitoring this situation very closely and will continue to 
    test influenza viruses and update information on resistance throughout the 
    influenza season. 



  

    


    
• Recommendations regarding the use of antiviral medications have been 
    reviewed and updated guidance will be issued given surveillance data 
    indicating an increase in the number of oseltamivir-resistant influenza H1N1 
    viruses in the United States. 



  

    


    
• Different optio ns for antiviral treatment in the setting of increased 
    circulation of oseltamivir-resistant H1N1 viruses have been considered. 
    These options, such as use of zanamivir or combination therapy with 
    oseltamivir and rimantadine, were outlined in the 2008 influenza 
    recommendations. 


2 of 3 December 19, 
  2008 Influenza Antiviral Resistance: Discussion Points 
  (continued from previous page) 

  

    


  =2
0 
• CDC’s interim guidance on the use of influenza antiviral medications 
    in the United States for the 2008-09 season will be issued in a Health Alert 
    Advisory on December 19. This revised guidance will be available at www.cdc.gov/flu. 
    



  

    


    
• Clinicians should be aware that revised interim guidance on the use of 
    antiviral medications is being provided by CDC for the current influenza 
    season and will be available at www.cdc.gov/flu. 



  

    


    
• Information from l ocal or state virus surveillance data and 
    laboratory testing can help clinicians in selecting appropriate antiviral 
    medications for their patients. 



  

    


    
• When influenza A (H1N1) virus infection or exposure is suspected, 
    zanamivir or a combination of oseltamivir and rimantadine are more 
    appropriate options than oseltamivir alone. 


    


    
• CDC is working to communicate this new guidance broadly through a 
    clinician communications campaign to alert health care providers to the 
    change in recommendations for antiviral medications this season. 
    


    


    
• 
Influenza 
    vaccines are expected to be effective in preventing or reducing the severity 
    of infection with currently circulating influenza viruses, including 
    oselt
amivir-resistant influenza A (H1N1) 

3 of 3 December 19, 2008 
  

 

  


  From: folk.devil at hotmail.com
To: gathering at misera.net
Date: Tue, 14 
  Jul 2009 10:17:12 -0700
Subject: Re: [kj] mark of the bea st closer than 
  expected


  
  Compulsory vaccination is suggested for the last Phase of an 
  epidemic.
Another strangeity is that H1N1 is resistant to 
  Tamiflu.
http://www.health.state.nm.us/FLU/docs/Antiviral%20Resistance_Background%20and%20Current%20Situation_partners_12_19.pdf
 

  


  From: dpeace at bigfoot.com
To: gathering at misera.net
Date: Tue, 14 
  Jul 2009 18:10:26 +0100
Subject: Re: [kj] mark of the beast closer than 
  expected


  

  

  

  
Have 
  you forgotten your meds again, Stephen?

  
 

  
Darren

  
Hungerford, 
  UK

  
 

  
(PS 
  No, I’ve not heard of any fast track programme. Link?)

  
 

  

  

  
From: gathering-bounces at misera.net 
  [mailto:gathering-bounces at misera.net] 
  On Behalf Of Stephen Lawrence
Sent: 14 July 2009 5:52 
  PM
To: gathering at misera.net
Subject: 
  [kj] mark of the beast closer than expected



  
 

  
anyone aware of 
  the SWINE FLU fast track vaccination programme ?
looks like the conspiracy 
  theorists were right 
they are talking about jab or jail 
hope my u s 
  trip isn't cut short 
how the fuck can you clinically trial a vaccine in a 
  coupla months ?
 
oh and 
it was a MOCK ONE btw 
not the shit 
  they wanna pump in our vains 
swine flu my arse 
more like de- 
  population
and surreptitious tagging 
welcome to minority report world 
  

  

  


  

  
Beyond Hotmail 
  - see what else you can do with Windows Live. Find out 
  more.



  


  Insert movie times and more without leaving Hotmail®. See how.

  


  Windows Live™: Keep your life in sync. Check it out.= 

  

_______________________________________________

Gathering mailing list

Gathering at misera.net

http://four.pairlist.net/mailman/listinfo/gathering




  


  


  What's for dinner tonight? Find quick and 
  easy dinner ideas for any occasion. 

  

  




  

_______________________________________________
Gathering mailing 
  list
Gathering at misera.net
http://four.pairlist.net/mailman/listinfo/gathering


 





_______________________________________________
Gathering mailing list
Gathering at misera.net
http://four.pairlist.net/mailman/listinfo/gathering



 

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://four.pairlist.net/pipermail/gathering/attachments/20090714/a544c9c2/attachment.html>